1. FIRST LINE TREATMENT BY THE RIBVD REGIMEN ELICITS HIGH CLINICAL AND MOLECULAR RESPONSE RATES AND PROLONGED SURVIVAL IN ELDERLY MCL PATIENTS; FINAL RESULTS OF a LYSA GROUP TRIAL. (June 2017) Authors: Gressin, R.; Daguindau, N.; Tempescul, A.; Moreau, A.; Carras, S.; Cartron, G.; Schmitt, A.; Houot, R.; Dartigeas, C.; Pignon, J.; Corm, S.; Bannos, A.; Mounier, C.; Dupuis, J.; Macro, M.; Fleury, J.; Jardin, F.; Karlin, L.; Damaj, G.; Feugier, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 199TiP A first-in-human phase I study of IPH5301, an anti-CD73 monoclonal antibody, alone or in combination with chemotherapy and trastuzumab, in patients with advanced solid tumors (CHANCES). (December 2022) Authors: Gonçalves, A.; Vicier, C.; Guerin, M.; Pignon, J.; Chanez, B.; Provansal Gross, M.; Penel, N.; Kotecki, N.; Marie, D.B.; Boyer Chammard, A.; Paturel, C.L.; André, P.; Pakradouni, J.; Boher, J.M.; Awada, F. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Thermochemical recovery technology for improved modern engine fuel economy – part 1: analysis of a prototype exhaust gas fuel reformer. Issue 44 (16th May 2015) Authors: Fennell, D.; Herreros, J.; Tsolakis, A.; Cockle, K.; Pignon, J.; Millington, P. Journal: RSC advances Issue: Volume 5:Issue 44(2015) Page Start: 35252 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗